AcquisitionOther
BioMarin Pharmaceutical Inc. acquired Inozyme Pharma, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
BioMarin Pharmaceutical Inc. -> Inozyme Pharma, Inc. · $270 million
acquire an important medicine that has the potential to be the first treatment for children and adults with ENPP1 Deficiency
Open source record (SEC) ↗